As a French biotech company, we are developing products for tissue regeneration utilizing matrix therapy to improve the life of patients who suffer dermatological or neurological disorders.
OTR3 was founded by two well-known biologists: Pr. Denis Barritault and Pr. Jean-Pierre Caruelle.
Thanks to their pioneering work on growth factors (FGF, HARP/PTN discovery) and medical and industrial long-term vision, they invented and patented the RGTA® or ReGeneraTing Agents technology, a new therapeutic class based on heparan sulfate mimetics.